OUTCOMES OF COMMERCIAL AND IN-HOUSE ANTI CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL LYMPHOMA IN SINGAPORE

被引：0
作者：
Ong, Shin Yeu [1 ]
Krisnadi, Cindy [1 ]
Wang, Samuel Sherng Young [1 ]
Chen, Yun Xin [1 ]
Seng, Michaela Su-fern [2 ]
Soh, Shui Yen [2 ]
Chan, Esther Hian Li [3 ]
Hwang, William Ying Khee [1 ]
Ho, Aloysius Yew Leng [1 ]
Lim, Francesca Lorraine Wei Inng [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
[2] KK Womens & Childrens Hosp, Singapore, Singapore
[3] Natl Univ Canc Inst, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P120
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [31] CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
    Park, Jae H.
    Nath, Karthik
    Devlin, Sean M.
    Sauter, Craig S.
    Palomba, M. Lia
    Shah, Gunjan
    Dahi, Parastoo
    Lin, Richard J. J.
    Scordo, Michael
    Perales, Miguel-Angel
    Shouval, Roni
    Tomas, Ana Alarcon
    Cathcart, Elizabeth
    Mead, Elena
    Santomasso, Bianca
    Holodny, Andrei
    Brentjens, Renier J.
    Riviere, Isabelle
    Sadelain, Michel
    NATURE MEDICINE, 2023, 29 (07) : 1710 - +
  • [32] A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
    Larson, Sarah M.
    Chen, Yvonne Y.
    Johnston, Jim
    Roy, Sylvain
    Patel, Pinakin
    Benjamin, Jonathan E.
    BLOOD, 2023, 142
  • [33] Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
    Hirayama, Alexandre Vinaud
    Fiorenza, Salvatore
    Gauthier, Jordan
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Kimble, Erik L.
    Pender, Barbara S.
    Kirchmeier, Delaney R.
    Di, Henna A.
    Cassaday, Ryan D.
    Chapuis, Aude G.
    Green, Damian J.
    Kiem, Hans-Peter
    Milano, Filippo
    Shadman, Mazyar
    Till, Brian G.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2022, 140 : 7447 - 7449
  • [34] Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma
    Samples, Laura S.
    Sadrzadeh, Hossein
    Frigault, Matthew J.
    Jacobson, Caron Alyce
    Hamadani, Mehdi
    Gurumurthi, Ashwath
    Strati, Paolo
    Shouval, Roni
    Riedell, Peter A.
    Dahiya, Saurabh
    Yared, Jean
    Jain, Michael D.
    Locke, Frederick L.
    Leslie, Lori Ann
    Epperla, Narendranath
    Ghosh, Monalisa
    Skarbnik, Alan
    Hill, Brian T.
    Kamdar, Manali K.
    Shadman, Mazyar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study
    Shen, Rong
    Cao, Wei-Guo
    Wang, Li
    Sheng, Ling-Shuang
    Zhang, Yi-Lun
    Wu, Wen
    Xu, Peng-Peng
    Cheng, Shu
    Liu, Meng-Ke
    Dong, Yan
    Wang, Yue
    Weng, Xiang-Qin
    Jiang, Xu-Feng
    Song, Qi
    Yi, Hong-Mei
    Li, Lei
    Chen, Sheng
    Yan, Zi-Xun
    Zhao, Wei-Li
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (04):
  • [36] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [37] Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    Nastoupil, Loretta J.
    Jain, Michael D.
    Spiegel, Jay Y.
    Ghobadi, Armin
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew A.
    Lekakis, Lazaros J.
    Reagan, Patrick M.
    Oluwole, Olalekan O.
    McGuirk, Joseph P.
    Deol, Abhinav
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier
    Westin, Jason R.
    Chavez, Julio C.
    Cashen, Amanda F.
    Bennani, Nora N.
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Locke, Frederick L.
    BLOOD, 2018, 132
  • [38] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [39] Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Abramson, Jeremy S.
    Johnson, Patrick Connor
    Jacobson, Caron A.
    Patel, C. G.
    HAEMATOLOGICA, 2023, 108 (11) : 2972 - 2981
  • [40] Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma
    Xu, Hao
    Lv, Qiuxia
    Huang, Liang
    Cao, Wenyue
    Wang, Jue
    Meng, Fankai
    Li, Chunrui
    Zheng, Miao
    Chen, Liting
    Mu, Ketao
    Cheng, Jiali
    Zhu, Li
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Cao, Yang
    CYTOTHERAPY, 2023, 25 (02) : 185 - 191
12345